Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Search clinical trials for: Pred Forte
Total 0 results
Nothing found
Sponsors and Collaborators
Duke Clinical and Translational Science Institute (CTSI), part of the NIH Clinical and Translational Science Awards (CTSA)
The Marfan Foundation
Skidmore College
Villarreal CF
Psoriasis Association
Luigi Canullo
Wellcome Leap Organization
Avextra Pharma GmbH
Else Kröner-Fresenius Stiftung, Bad Homburg, Germany
Stemina Biomarker Discovery, Inc.
Deutsche Klinik Bad Münder
Stefano Malinverni, MD
CellOxess LLC
Natrol
Bayfront Health St Petersburg
Aider Perpignan : Dr Ahmed RACHI
L. Eugene Arnold
Sligo General Hospital
Dong-A Pharmaceutical Co., Ltd.
Microsoft Corporation
View Full List
Medical Conditions
Primary Renal Transplant
Epithelial Hyperplasia Without Atypia
Stage I Prostate Adenocarcinoma American Joint Committee on Cancer (AJCC) v7
Gastroparesis Due to Diabetes Mellitus Type I
Epidermolysis Bullosa Simplex, Generalized
Left Ventricular (LV) Systolic Dysfunction
Non Throwing Shoulders
Cystoscope
Erector Spinae Plane Block
Colonic Diseases
Stage IVC Mucosal Melanoma of the Head and Neck AJCC v7
Dental Carie; Orthodontics
Double Lumen Endotracheal Tube
STRETCHING
ACL Reconstruction
Perioperative Sedation
Stage II Adult Liver Cancer
Wound Infection or Endometritis Post Cesarean Section
Acute Tubulo-Interstitial Nephritis
Myocardial Bridge of Coronary Artery
View Full List
Drug Interventions
Esomeprazole
Nogapendekin Alfa
INCB009471
Standard of care
0.03% DSC127 topical gel
YY-20394 treatment
PZA sensitivity guided ultra-short all Oral Regimen
36 Weeks Methylprednisolone
Hydroxychloroquine
Pertuzumab IV
BeneFIX
Paliperidone ER
Keytruda
Tobramycin
Eribulin Mesylate
Brivanib
PEP005 (Ingenol mebutat Gel, 0.05 %)
Paricalcitol
Temozolomide
Resin infiltration
View Full List
CROs by country
Contract Research Organizations in Bangladesh
Contract Research Organizations in Burundi
Contract Research Organizations in Congo, DR of
Contract Research Organizations in Djibouti
Contract Research Organizations in Ecuador
Contract Research Organizations in Lithuania
Contract Research Organizations in Moldova
Contract Research Organizations in Montenegro
Contract Research Organizations in Nigeria
Contract Research Organizations in Peru
Contract Research Organizations in Saint Lucia
Contract Research Organizations in Senegal
Contract Research Organizations in Switzerland
CRO list by country
CROs in Azerbaijan
SGS
BiTrial Clinical Research
ROSENBAUM GROUP
All CROs in Azerbaijan
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe